Purchase Order 68HE0726P0136
- Not listed
- The U.S. Environmental Protection Agency (EPA) Office of Research and Development awarded a firm fixed-price purchase order for $277,750.00 to Illumina, Inc. to provide an Illumina NextSeq 550 Sequencing System with accessories, installation, and training. This contract supports the EPA's genomic sequencing and analysis capabilities. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided similar equipment and services to...
- The Environmental Protection Agency Office of Research and Development awarded a $37,040.86 firm fixed price purchase order to Illumina, Inc. of San Diego, California for Illumina sequencing kits to support the agency's Pollution and Ecosystems Division. No set-aside provisions were included. Performance will occur in San Diego through May 2024. As a manufacturer and provider of sequencing and array-based solutions, Illumina will deliver its sample preparation and sequencing kits to support...
- This is a firm fixed price purchase order awarded by the Environmental Protection Agency's (EPA) Office of Research and Development to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract, valued at $13,888.29, is for the provision of Illumina sequencing reagents and kits to support the agency's FY24 REICHMAN research programs focused on PFAS (per- and polyfluoroalkyl substances) and other scientific priorities. The award has a period of...
- The Environmental Protection Agency (EPA) Office of Research and Development awarded Illumina, Inc. a firm fixed price purchase order worth $8,712.00 to move and re-install the Illumina MiSeq system. The contract has a completion date of March 20, 2024 and does not utilize a set-aside. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously supported genomic research and diagnostics for agencies like the National Institutes of Health (NIH),...
- The Environmental Protection Agency (EPA) Office of Research and Development awarded a $18,757.60 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the repair of Illumina MiSeq instruments. This award does not have a set-aside designation. Illumina has previously received federal contracts from agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Department of...
- The Environmental Protection Agency's Office of Research and Development awarded Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments, a firm fixed price purchase order for a service maintenance agreement on a NextSeq sequencing system. The agreement has a base period of performance through May 19, 2024, with two optional renewal years, for a potential total value of $113,698.00. Illumina has previously received prime contract awards from federal agencies such as the...
- This federal contract award is for an annual maintenance agreement for a MiSeq Silver Support Plan with the U.S. Environmental Protection Agency (EPA) Office of Research and Development. The contract, valued at $15,575.00, was awarded to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. This purchase order contract has a firm fixed price pricing type and does not utilize any set-aside provisions. Illumina has previously been awarded prime contracts by...
- The Environmental Protection Agency Office of Research and Development awarded a firm fixed price purchase order valued at twenty-two thousand sixty-five dollars and thirty-eight cents ($22,065.38) to Illumina, Inc. to provide an Illumina NextSeq 500/550 High Output Kit V2.5. The award references Federal Acquisition Regulation 25.104(a) for spare and replacement parts for equipment of foreign manufacture where domestic parts are unavailable. Performance will take place in San Diego, California...
- The U.S. Environmental Protection Agency Office of Research and Development awarded a $40,084.80 firm fixed-price purchase order contract to Illumina, Inc. for the NEXTSEQ 550 SYSTEM SILVER SUPPORT MAINTENANCE AGREEMENT. This sole-source contract provides maintenance and repair services for a NextSeq sequencing instrument, serial number NS500611, used in the agency's research activities. Illumina, a biotechnology company specializing in genetic sequencing technologies, is the original...
- The Environmental Protection Agency Office of Research and Development awarded a $40,910.00 firm fixed price purchase order to Illumina, Inc. for a NextSeq 550 System Silver Support Maintenance Agreement. Illumina is a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The contract provides maintenance, repair, and technical support services for the EPA's NextSeq 550 System over a period ending on April 16, 2025. This sole source award is not set aside for any...
The Environmental Protection Agency Region 7 awarded a $119,366.43 firm fixed-price purchase order to Illumina, Inc. for a nucleic acid sequencer to support laboratory operations at South Park Village, Washington. The award was issued on March 13, 2026, with an ultimate completion date of June 12, 2026, and carries no set-aside designation. Illumina is a San Diego-based biotechnology manufacturer specializing in genetic sequencing and genomic analysis instruments, with extensive federal contracting experience across civilian and defense agencies including the Department of Veterans Affairs, National Institutes of Health, Food and Drug Administration, and the U.S. Department of Agriculture. This purchase order represents a routine acquisition of core laboratory equipment from Illumina's portfolio of sequencing platforms, which support EPA research initiatives in environmental monitoring and analysis. Illumina maintains significant federal contracting relationships, including a $45 million indefinite delivery contract with USDA effective through June 2030, reflecting its established role as a primary provider of genomic sequencing technologies to federal research institutions. The firm fixed-price structure and direct award to Illumina reflect the specialized and proprietary nature of the sequencing equipment, positioning the company as a sole-source vendor for this category of advanced laboratory instrumentation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119.4k | 3/12/26 |